Find a copy online
Find a copy in the library
Finding libraries that hold this item...
Details
Genre/Form: | Electronic books Trials, litigation, etc History Cases Jurisprudence |
---|---|
Additional Physical Format: | Print version: Carreyrou, John. Bad blood. New York : Vintage Books, a division of Penguin Random House LLC, 2020 (DLC) 2019300476 (OCoLC)1059317847 |
Named Person: | Elizabeth Holmes |
Material Type: | Document, Internet resource |
Document Type: | Internet Resource, Computer File |
All Authors / Contributors: |
John Carreyrou |
ISBN: | 9781524731663 1524731668 |
OCLC Number: | 1030992480 |
Description: | 1 online resource : illustrations |
Contents: | A purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\day -- Going live -- Unicorn -- The grandson -- Fame -- The Hippocratic oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes -- Epilogue. |
Other Titles: | Secrets and lies in a Silicon Valley startup |
Responsibility: | John Carreyrou. |
Abstract:
"The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--
Reviews
User-contributed reviews
Add a review and share your thoughts with other readers.
Be the first.
Add a review and share your thoughts with other readers.
Be the first.


Tags
Add tags for "Bad blood : secrets and lies in a Silicon Valley startup".
Be the first.
Similar Items
Related Subjects:(23)
- Holmes, Elizabeth, -- 1984-
- Theranos (Firm) -- History.
- Hematologic equipment industry -- United States.
- Fraud -- United States.
- New business enterprises -- Corrupt practices -- United States -- Cases.
- Securities fraud -- United States -- Cases.
- Fraud.
- Fraud
- United States
- Hématologie -- Appareils et matériel -- Industrie -- États-Unis.
- Fraude -- États-Unis.
- Nouvelles entreprises -- Pratiques déloyales -- États-Unis -- Jurisprudence.
- Fraude boursière -- États-Unis -- Jurisprudence.
- Fraude.
- fraud.
- BUSINESS & ECONOMICS -- Entrepreneurship.
- BUSINESS & ECONOMICS -- Finance.
- TECHNOLOGY & ENGINEERING -- Biomedical.
- BUSINESS & ECONOMICS -- Industries -- General.
- Theranos (Firm)
- Securities fraud.
- Hematologic equipment industry.
- United States.
User lists with this item (1)
- Financial Times - Best Business Books 2008-2019(171 items)
by adwheatley updated 2019-12-03